Trond Ulven
Professor
PROFESSIONAL EXPERIENCE
1/18-present: Professor of Medicinal Chemistry, Department of Drug Design and Pharmacology, University of Copenhagen
7/2017-12/2018: Professor of Medicinal Chemistry, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark
10/2015–present: Director and co-founder, Caldan Therapeutics
10/2012-6/2017: Professor of Pharmaceutical Chemistry with special responsibilities in entrepreneurship, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark
9/2005–9/2012: Associate Professor of Medicinal Chemistry, Department of Physics and Chemistry, University of Southern Denmark
9/2001–8/2005: Senior Scientist, 7TM Pharma A/S, Hørsholm, Denmark
1/2000–8/2001: Postdoctoral Research Associate, The Scripps Research Institute, San Diego, USA
EDUCATION
1999: Doctor engineer (dr.ing.) of Organic Chemistry, Norwegian University of Science and Technology (NTNU), Faculty of Chemistry and Biology, Department of Organic Chemistry
1994: Civil engineer (siv.ing.) of Organic Chemistry Norwegian Institute of Technology (NTH)
1992: Examen philosophicum, University of Trondheim, Norway
ID: 187375453
Most downloads
-
275
downloads
Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic Properties
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
109
downloads
Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
108
downloads
Dihydropyridine Fluorophores Allow for Specific Detection of Human Antibodies in Serum
Research output: Contribution to journal › Journal article › Research › peer-review
Published